ODDB.org: Open Drug Database

Fresenius Kabi (Schweiz) AG - Irinotecan Fresenius 40 mg/2 ml, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	61246	Sequence	01
Product name	Irinotecan Fresenius 40 mg/2 ml	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	L01XX19	ATC-Description	Irinotecan
Introduction of Sequence	28.01.2011

Composition

irinotecani hydrochloridum trihydricum 40 mg, sorbitolum 90 mg, acidum lacticum, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 2 ml.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	40mg / 2ml

BAG: Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	40 mg

Inactive agents	Dose
Acidum Hydrochloridum ad Ph
Lactic Acid
Natrii Hydroxidum ad Ph
Sorbitol	90mg / 2ml

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
017		37.83	57.55	A	SL	No

2025	©ywesee GmbH